-

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:

Eurofins (Paris:ERF):

Name of the Issuer

Identify code of the Issuer

Transaction day

Identify code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC Code)

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

20/07/2026

FR0014000MR3

3 180

70.8332

CEUX

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

20/07/2026

FR0014000MR3

6 820

70.7743

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

21/07/2026

FR0014000MR3

10 000

69.6146

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

21/07/2026

FR0014000MR3

5 000

69.5791

CEUX

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

22/07/2026

FR0014000MR3

15 000

69.9803

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

22/07/2026

FR0014000MR3

5 000

70.0877

CEUX

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

23/07/2026

FR0014000MR3

5 000

66.7730

CEUX

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

23/07/2026

FR0014000MR3

10 000

66.7916

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

24/07/2026

FR0014000MR3

20 000

66.1575

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

24/07/2026

FR0014000MR3

5 000

66.1178

CEUX

 

 

 

TOTAL

85 000

68.3251

 

Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes

Contacts

Eurofins

Eurofins

BOURSE:ERF
Release Versions
English

Contacts

Eurofins

More News From Eurofins

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Financial highlights in H1 2026 Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives. Revenues of €3,701m increased by 2.5% as reported including a 2.9% headwind from foreign currency, and 2.7% organically13. Organic growth13 improved as the half...

Eurofins Scientific SE: Weekly Report on Share Repurchases from 13th July to 17th July 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Weekly report on share repurchases from 13th July to 17th July 2026   Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/07/2026 FR0014000MR3 15 000 69.1984 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/07...

Eurofins Agrees to Acquire Element Materials Technology’s Life Sciences Testing Services Business in North America

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (EUFI.PA) (Paris:ERF), a global scientific leader in bioanalytical testing, has reached an agreement with Element Materials Technology (“Element”) to acquire its Life Sciences Testing Services business in North America, for an enterprise value of $400m. The transaction is subject to customary conditions, including regulatory approvals, and is expected to close in Q4 2026. Element’s North America Life Sciences Testing Services inc...
Back to Newsroom